Efficacy Evaluation of the (Serodase 5 mg Tablet) in the Treatment of Inflammation After Third Molar Surgery

Phase 4 Unknown 112 enrolled Hayat Pharmaceutical Co. PLC

RandomizedParallel-groupTriple-blindTreatment

Summary

The purpose of this study is to examine the efficacy of dose regimen of serratiopeptidase (serodase 5 mg) as a prospective, randomized, parallel, double blind Placebo- controlled study.

Timeline

Start: 2015-06
Primary completion: 2016-01
Completion: 2016-02

Publications

Tamimi Z, Al Habashneh R, Hamad I, Al-Ghazawi M, Roqa'a AA, Kharashgeh H. Efficacy of serratiopeptidase after impacted third molar surgery: a randomized controlled clinical trial. BMC Oral Health. 2021 Mar 2;21(1):91. doi: 10.1186/s12903-021-01451-0.

Drugs

Evaluation	Drug	Modality	Dose	Route
Comparator	Serodase	Unknown	10 mg	—

Indications

No indication recorded.